Apple's $634M payment to Masimo finalized after appeal rejected
Apple Watch sales ban lifted, but compensation payment confirmed.
1Case outcome
The permanent ban on Apple Watch sales and the use of the blood oxygen sensor was denied. However, Apple will have to pay $634 million to Masimo's new owner Danaher. This decision became final after Apple's appeal was rejected.
2Blood oxygen sensor
Apple Watch users have been able to continue using the blood oxygen sensor thanks to a software update released in January 2024. This update effectively nullified the sales ban, and Masimo's efforts to reinstate the ban were unsuccessful.
3Appeal process
Apple appealed the jury's decision based on the definition of a 'patient monitor.' However, U.S. District Judge James V. Selna denied Apple's request. This ruling definitively ended the case and mandated Apple's compensation payment.
4Masimo's position
Masimo claimed that Apple used its blood oxygen sensor technology in patent infringement. The company fought to maintain the sales ban but ultimately failed to achieve this goal due to the software update and appeal process.
5Apple's strategy
Apple successfully bypassed the sales ban with a software update. This move allowed the company to continue selling its products while closing the case with a compensation payment. For Apple, this outcome was a solution that minimized legal risks.
6Industry impact
This case serves as an important example of how tech giants can strategize in patent infringement lawsuits. Apple's bypass of the ban through a software update could guide other companies in similar legal battles.
Original article: AppleInsider News — Apple'ın Masimo'ya ödeyeceği 634 milyon dolar kesinleşti